APTARGROUP, INC.

ATR NYSE CIK: 0000896622

Company Information

Industry Plastics Products, NEC
SIC Code 3089
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 265 EXCHANGE DRIVE, CRYSTAL LAKE, IL, 60014
Mailing Address 265 EXCHANGE DRIVE, CRYSTAL LAKE, IL, 60014
Phone 8154770424
Fiscal Year End 1231
EIN 363853103

Financial Overview

FY2025 FY

$3.78B
Revenue
$392.79M
Net Income

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement March 27, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC

Annual Reports

10-K February 6, 2026
  • Global leader in dispensing, sealing, and active packaging solutions across Pharma, Beauty, and Closures segments.
  • Achieved moderate revenue growth in 2025, primarily driven by strategic acquisitions and strong segment performance.
View Analysis

Material Events

8-K Leadership Change March 17, 2026
High Impact
  • Internal promotion of Gael Touya ensures continuity and leverages deep institutional knowledge within AptarGroup.
  • The transition is designed to sustain strategic momentum, particularly within the high-growth pharmaceutical sector.
View Analysis

Insider Trading

STRONG SELL 3 insiders 3 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3089)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.